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Introduction
ATM (ataxia telangiectasia mutated) coordinates cell-cycle checkpoints with DNA repair in response to DNA damage 1 . ATM can be activated by the MRN complex (MRE11/RAD50/NBS1) via interaction with NBS1 2 but can also be activated by the ATM interactor ATMIN 3, also known as ASCIZ (McNees at al, 2005 EMBO J). ATMIN has a complementary function to NBS1: NBS1 is required for ionizing radiation-induced ATM signaling, whereas ATMIN is required for ATM activation following hypotonic or replication stress [3] [4] [5] .
ATMIN has been shown to function in conditions of oxidative stress and aging 6 and also as a transcription factor 7 . We have previously shown that ATMIN-deleted B cells (induced by CD19-Cre) have impaired class switch recombination and increased genomic instability, leading to B cell lymphomas 8 . In contrast, mice conditionally deleted of Atmin using Mx1-Cre developed B cell lymphopenia 9 . It is unclear whether the lack of B cell lymphoma formation in this mouse model is due to a B cell developmental defect or to other deficiencies in primitive hematopoietic cells that prevent the accumulation of genetically unstable cells. Since the role of ATMIN in hematopoietic stem/progenitor cells is currently unknown, we sought to investigate a possible role for ATMIN in primitive hematopoietic cells and whether this would be ATM-dependent or -independent.
Materials and Methods

Vav-Atmin Δ/Δ mice
Atmin f/f mice (described previously 6, 8 ) were crossed with heterozygous Vav-Cre mice to generate Vav-Atmin ∆/∆ mice. Gene deletion efficiency and genotyping was determined by PCR using primers specific for the floxed exon 4, deleted exon 4, WT Atmin alleles and for Vav-Cre and immunoblotting (Figures S1A and S1B and Table S1 ).
Intracellular immunostaining
Briefly 10 , cells were incubated with antibodies against extracellular antigens then fixed in PBS with 2% methanol-free formaldehyde at room temperature (RT) (for Ki-67, BD Biosciences) or at 37°C (for pS824-Kap1, Bethyl Laboratories; Bim, Cell Signaling; pS139-γH2AX, Abcam) for 10 min.
Cells were permeabilized with PBS containing 0.1% Triton-X-100 (Sigma) for 10 min at RT, blocked using PBS containing 5% serum for 15 min and incubated with primary antibodies at 4°C for 1 hour, followed by appropriate secondary antibodies in the same conditions. Cells were resuspended with PBS/2% FBS containing DAPI and pulse processing was used to exclude any unstained, apoptotic and clumped cells. Please see Supplementary Information for more detailed Methods.
Results and discussion
Vav-Atmin ∆/∆ mice were born healthy and were not anemic but were leukopenic at 8-12 weeks (Figure S1C-D). Unlike the CD19-Cre model 8 , mice did not develop lymphoma even in aged mice, and instead numbers of splenic B cells were reduced ( Figure S2A -B) which resulted in a complete absence of germinal centers (GC) ( Figure S2C ). B cell apoptosis was increased, and while ROS levels were unaffected there was a pronounced reduction in Dynll1 expression, as previously described 9 ( Figure S2D In young ATMIN-deficient mice (8-12 weeks), a ~40% reduction in BM cellularity was observed across all cell types, with a prominent reduction in the frequency of common myeloid progenitors (CMPs) ( Figure S3A Figure 2N ). There were no apparent signs of senescence (such as increased p16 Ink4a and p19 Arf expression) in any of the aged ATMIN-deficient primitive sub-populations (data not shown) and no increase in ROS production in ATMIN-deficient LT-HSCs was observed ( Figure S3J ), unlike in Atm -/mice 12,13 . Contrary to young cells, we observed a significant increase in expression of DNA oxidation repair genes in aged ATMIN-deficient LT-HSCs, as well as an increase in pKap1, suggesting that both aging and ATMIN deficiency are required to stimulate this response ( Figure 2O -P).
Regeneration of PB hematopoiesis after myelo-suppressive 5-FU treatment was much weaker in ATMIN-deficient compared with control mice ( Figure   2Q ). ATMIN-deficient LT-HSCs cycled less and showed an increased DNA damage response compared with control cells at day 7 post-5-FU treatment 
Hematopoietic analyses
Single-cell suspensions were first obtained from different hematopoietic tissues, then red blood cells were lysed and samples stained for 30 min. at 4°C with the indicated antibodies in PBS supplemented with 2% FCS (PBS/2%). DAPI was added to exclude dead cells in the flow cytometry analysis. For complete blood counts, peripheral blood was collected from the tail vein into tubes containing K 2 EDTA. Twenty-five µl of blood was stained for different leukocyte antigens as described then without washing diluted to 1 ml and analysed in a MACSQuant analyser (Miltenyi Biotec). For red blood cell counts, blood was diluted 1:1000 and red cells were counted in a hemocytometer. The following antibodies (from BD Bioscience and eBioscience) were used: Lineage cocktail, CD45.1 (A20), CD45.2 (104), B220 (RA3-6B2), Ly-6G (Gr1; RB6-8C5), CD3 (17A2), Sca-1 (D7), CD117 (c-Kit; 2B8), CD34 (RAM34), CD16/32 (93), CD43 (S7), IgM (II/41), CD135 (Flt3; A2F10), CD127 (IL7Rα; A7R34) and AnnexinV.
Analysis of intracellular ROS and mitochondria.
Cells were incubated with the ROS detection agent DCFDA (carboxy-H 2 DFFDA C13293; Life Technologies) at 5 µM or MitoTrackerRed-CMXRos (M7512; Life Technologies) at 12.5 nM and incubated at 37°C for 30 min.
After this period cells were washed with PBS/2% FBS containing trypan blue to quench nonspecific staining.
Gene Expression Analysis
RNA was extracted using the RNeasy Micro Kit (Qiagen, Inc.) and treated with DNase.
Reverse transcription was performed using the Table S1 .
CAFC and LTC-IC-CFC assays
Briefly, FACS purified L -S + K + cells were co-cultured as bulk or using a limiting dilution analysis (LDA) both on 80% confluent monolayer of MS5 and method of maximum likelihood. For LTC-IC-derived colonies, cells were recovered after 5 wks of co-culture and plated on standard methylcellulose colony assay media as described below.
Colony assays
Standard methylcellulose colony assay media, MethoCult ® GF M3534
was used according to the manufacturer's instructions. NAC (N-acetyl cysteine; Sigma) or γ-GCE (glutathione monoethyl ester; Calbiochem) was added to the methylcellulose at 100 µM or 2 mM respectively when cells were seeded and then at day 5. Colonies were scored at day 10.
Immunohistochemistry
Tissue was fixed overnight in 10% neutral buffered formalin, briefly washed with PBS and transferred into 70% ethanol, processed and embedded into paraffin. Sections were cut at 4 µm for H&E staining.
Western blotting
Cells were extracted in RIPA lysis buffer (NEB) supplemented with protease inhibitors (Sigma). Western blots were performed using standard procedures. Protein samples were separated by SDS-PAGE, and subsequently transferred onto nitrocellulose membranes. All primary antibodies were used at 1:1000 dilution and secondary antibodies at 1:2000.
The following antibodies were used: p-S824-Kap1 (Bethyl Laboratories, Inc); ATMIN, (Millipore); β-actin (Sigma); α−tubulin (Abcam); HRP-conjugated goat anti-mouse/rabbit IgG (Sigma).
ImageStream analysis
Cells were stained first for extracellular antigens followed by mitochondria staining. Cells were then fixed, permeabilized and stained for 
